 Circulating low-density neutrophils of breast cancer patients are associated with their worst prognosis due to the impairment of T-cell responses. Neutrophils are the most abundant type of white blood cell. Neutrophils can either have anti-tumor or pro-tumor activity, dependent on the density of the circulating neutrophils. In a trending research paper published by Alka Target in 2021, researchers evaluated the impact of circulating low-density neutrophils in patients with breast cancer and its association with poor prognosis. Read this paper and more peer-reviewed oncology-focused research published by AlkaTarget at AlkaTarget.com